Replies to post #15698 on GTC Biotherapeutics (fka GTCB)

[oldberkeley]

>A small, struggling MA biotech gets unsolicited buyout offer for approx 300% above current trading at time...<

And if that highly unlikely scenario occurred here, we'd be at the magnificent figure of 0.39 PPS.

For new buyers coming in at this level- and I think that there are many- things might work out great. But IMHO there are no more good scenarios for long-term holders, only those that contain either more or less pain.

[quantumdot]

NTMD - the offer came because they were trading significantly below their cash reserves.

I wouldn't hope for any similar buy-out of GTCB soon. They are the polar opposite to NTMD. GTCB continues to trade significantly above their cash reserves and have already pledged their IP to LFB and their assets to GE. Why on earth would anybody make a similar offer for GTCB?